FRAZIER Company Profile

03:46 EDT 20th March 2018 | BioPortfolio

In the ever-complex world of healthcare, your partnership with a venture capital firm can truly make the difference between success and failure. At Frazier Healthcare Ventures, we understand the unique challenges and risks facing a growing entrepreneurial company in the healthcare industry because our sole focus is-and always has been-healthcare investing.
Founded in 1991 and with more than $1.2 billion of capital under management, Frazier Healthcare is one of the nation's leading providers of venture and growth equity capital to emerging healthcare companies. Having invested in more than 85 emerging healthcare companies, Frazier Healthcare is well known for its depth of experience and the technical expertise of its investment team. This experience encompasses product development and launch, clinical trial implementation and design, industry operating experience, academic research and clinical practice.


601 UnionTwo Union Square
Suite 3200
United States of America


Phone: 206.621.7200
Fax: 206.621.1848

News Articles [20 Associated News Articles listed on BioPortfolio]

Frazier follows performance

How Frazier Healthcare Partners plans to ramp up company creation. Plus: Aisling plays small ball; and new LPs flock to BioGeneration’s largest fund yet.

Frazier Healthcare Partners Closes Oversubscribed $419M Life Sciences Fund

NewsFrazier Life Sciences IX will target two-thirds of its investments in Seed and Series A rounds.Contributed Author: 

Frazier Healthcare Partners Closes Oversubscribed $419 Million Life Sciences Fund

Frazier Healthcare Partners announced today the closing of Frazier Life Sciences IX, L.P., exceeding its target and closing on nearly $419 million in capital commitments in an ove...

Frazier closes $419M life sciences fund

Merck's (MRK) CEO Ken Frazier on Q4 2017 Results - Earnings Call Transcript

Frazier-Backed Mavupharma Scores $20M to Fund STING Program

The Series A funding will be used primarily to advance Mavu's lead drug candidates into the clinic.

Executive of the Year: Kenneth Frazier

Merck's CEO has navigated the company through some of its most difficult years and brought it back to its science-focused roots, while also standing out as a pillar of morality. 

Corner Office: Merck C.E.O. Ken Frazier on Death Row Cases and the Corporate Soul

Business leaders today are reshaping the internet, reimagining health care, upending transportation and more. But being a chief executive is no longer just about running a company.

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD)

This study aims towards investigating the efficacy of a near-infrared spectroscopy (NIRS)-based neurofeedback training in a virtual reality (VR) classroom in schoolchildren with attention-...

Companies [15 Associated Companies listed on BioPortfolio]

Frazier Healthcare

Founded in 1991, Frazier Healthcare is a leading provider of growth equity and venture capital to high growth and emerging healthcare service, biopharma and medical device compani...

Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a leading provider of growth capital to healthcare companies. The firm has over $2.4 billion in committed capital under management ...


In the ever-complex world of healthcare, your partnership with a venture capital firm can truly make the difference between success and failure. At Frazier Healthcare Ventures, we understand the uniqu...

Atterocor, Inc.

Atterocor is a drug development company focused on novel therapies for adrenal cancer. The Company launched in 2012 with a Series A financing led by top-tier life sciences investo...

Stromedix, Inc.

Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in Stromedix include A...

More Information about "FRAZIER" on BioPortfolio

We have published hundreds of FRAZIER news stories on BioPortfolio along with dozens of FRAZIER Clinical Trials and PubMed Articles about FRAZIER for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FRAZIER Companies in our database. You can also find out about relevant FRAZIER Drugs and Medications on this site too.

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record